Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial

Busulfan and cyclophosphamide (BuCy) is a frequently used myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation (allo-HCT). Theoretical considerations and pharmacological data indicate that application of busulfan prior to subsequent cyclophosphamide (BuCy) may trigger...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Hematol
Autors principals: Seydoux, Claire, Medinger, Michael, Gerull, Sabine, Halter, Joerg, Heim, Dominik, Chalandon, Yves, Levrat, Stavroula Masouridi, Schanz, Urs, Nair, Gayathri, Ansari, Marc, Simon, Patrick, Passweg, Jakob R., Cantoni, Nathan
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7782401/
https://ncbi.nlm.nih.gov/pubmed/33098041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04312-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars